SHLA-I contamination, a novel mechanism to explain Ex Vivo/In vitro modulation of IL-10 synthesis and release in CD8+ T lymphocytes and in neutrophils following intravenous immunoglobulin infusion

Massimo Ghio, Paola Contini, Maurizio Setti, Gianluca Ubezio, Clemente Mazzei, Gino Tripodi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Numerous mechanisms have been proposed to explain the beneficial action of intravenous immune globulin (IVIG) in autoimmune and systemic inflammatory disorders; among others, they could decrease pro-inflammatory cytokine levels and also induce anti-inflammatory cytokines. Materials and Methods: Ex vivo analysis of cells from ten IVIG recipients showed significant increase of IL-10 mRNA and intra-cellular IL-10 molecules in both leukotypes. Results: In vitro comparable results were obtained incubating CD8+ T lymphocytes and neutrophils from healthy donors with IVIG. sHLA-I and/or sFasL immunodepletion abolished IL-10 modulation. Co-culture with contaminant-free IgM or MabThera did not exert any mRNA modulation. Finally, IgM or MabThera plus purified sHLA-I molecules enhanced IL-10-mRNA in both leukotypes to levels comparable to those obtained with IVIG incubation. Conclusion: As IVIG infusion involves administration of soluble contaminants, these data consent to speculate that IVIG might modulate IL-10 via the immunomodulatory activities of sHLA-I contaminant molecules inducing transcriptional and post-transcriptional modulation of IL-10 in CD8+ T lymphocytes and neutrophils.

Original languageEnglish
Pages (from-to)384-392
Number of pages9
JournalJournal of Clinical Immunology
Volume30
Issue number3
DOIs
Publication statusPublished - May 2010

Fingerprint

Intravenous Immunoglobulins
Intravenous Infusions
Interleukin-10
Neutrophils
T-Lymphocytes
Messenger RNA
Immunoglobulin M
Cytokines
Coculture Techniques
In Vitro Techniques
Anti-Inflammatory Agents

Keywords

  • IL-10
  • Immunomodulation
  • IVIG
  • SHLA-I

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Medicine(all)

Cite this

SHLA-I contamination, a novel mechanism to explain Ex Vivo/In vitro modulation of IL-10 synthesis and release in CD8+ T lymphocytes and in neutrophils following intravenous immunoglobulin infusion. / Ghio, Massimo; Contini, Paola; Setti, Maurizio; Ubezio, Gianluca; Mazzei, Clemente; Tripodi, Gino.

In: Journal of Clinical Immunology, Vol. 30, No. 3, 05.2010, p. 384-392.

Research output: Contribution to journalArticle

@article{5bf84057daa14c5fa7bde1183bf5fd12,
title = "SHLA-I contamination, a novel mechanism to explain Ex Vivo/In vitro modulation of IL-10 synthesis and release in CD8+ T lymphocytes and in neutrophils following intravenous immunoglobulin infusion",
abstract = "Background: Numerous mechanisms have been proposed to explain the beneficial action of intravenous immune globulin (IVIG) in autoimmune and systemic inflammatory disorders; among others, they could decrease pro-inflammatory cytokine levels and also induce anti-inflammatory cytokines. Materials and Methods: Ex vivo analysis of cells from ten IVIG recipients showed significant increase of IL-10 mRNA and intra-cellular IL-10 molecules in both leukotypes. Results: In vitro comparable results were obtained incubating CD8+ T lymphocytes and neutrophils from healthy donors with IVIG. sHLA-I and/or sFasL immunodepletion abolished IL-10 modulation. Co-culture with contaminant-free IgM or MabThera did not exert any mRNA modulation. Finally, IgM or MabThera plus purified sHLA-I molecules enhanced IL-10-mRNA in both leukotypes to levels comparable to those obtained with IVIG incubation. Conclusion: As IVIG infusion involves administration of soluble contaminants, these data consent to speculate that IVIG might modulate IL-10 via the immunomodulatory activities of sHLA-I contaminant molecules inducing transcriptional and post-transcriptional modulation of IL-10 in CD8+ T lymphocytes and neutrophils.",
keywords = "IL-10, Immunomodulation, IVIG, SHLA-I",
author = "Massimo Ghio and Paola Contini and Maurizio Setti and Gianluca Ubezio and Clemente Mazzei and Gino Tripodi",
year = "2010",
month = "5",
doi = "10.1007/s10875-009-9364-y",
language = "English",
volume = "30",
pages = "384--392",
journal = "Journal of Clinical Immunology",
issn = "0271-9142",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - SHLA-I contamination, a novel mechanism to explain Ex Vivo/In vitro modulation of IL-10 synthesis and release in CD8+ T lymphocytes and in neutrophils following intravenous immunoglobulin infusion

AU - Ghio, Massimo

AU - Contini, Paola

AU - Setti, Maurizio

AU - Ubezio, Gianluca

AU - Mazzei, Clemente

AU - Tripodi, Gino

PY - 2010/5

Y1 - 2010/5

N2 - Background: Numerous mechanisms have been proposed to explain the beneficial action of intravenous immune globulin (IVIG) in autoimmune and systemic inflammatory disorders; among others, they could decrease pro-inflammatory cytokine levels and also induce anti-inflammatory cytokines. Materials and Methods: Ex vivo analysis of cells from ten IVIG recipients showed significant increase of IL-10 mRNA and intra-cellular IL-10 molecules in both leukotypes. Results: In vitro comparable results were obtained incubating CD8+ T lymphocytes and neutrophils from healthy donors with IVIG. sHLA-I and/or sFasL immunodepletion abolished IL-10 modulation. Co-culture with contaminant-free IgM or MabThera did not exert any mRNA modulation. Finally, IgM or MabThera plus purified sHLA-I molecules enhanced IL-10-mRNA in both leukotypes to levels comparable to those obtained with IVIG incubation. Conclusion: As IVIG infusion involves administration of soluble contaminants, these data consent to speculate that IVIG might modulate IL-10 via the immunomodulatory activities of sHLA-I contaminant molecules inducing transcriptional and post-transcriptional modulation of IL-10 in CD8+ T lymphocytes and neutrophils.

AB - Background: Numerous mechanisms have been proposed to explain the beneficial action of intravenous immune globulin (IVIG) in autoimmune and systemic inflammatory disorders; among others, they could decrease pro-inflammatory cytokine levels and also induce anti-inflammatory cytokines. Materials and Methods: Ex vivo analysis of cells from ten IVIG recipients showed significant increase of IL-10 mRNA and intra-cellular IL-10 molecules in both leukotypes. Results: In vitro comparable results were obtained incubating CD8+ T lymphocytes and neutrophils from healthy donors with IVIG. sHLA-I and/or sFasL immunodepletion abolished IL-10 modulation. Co-culture with contaminant-free IgM or MabThera did not exert any mRNA modulation. Finally, IgM or MabThera plus purified sHLA-I molecules enhanced IL-10-mRNA in both leukotypes to levels comparable to those obtained with IVIG incubation. Conclusion: As IVIG infusion involves administration of soluble contaminants, these data consent to speculate that IVIG might modulate IL-10 via the immunomodulatory activities of sHLA-I contaminant molecules inducing transcriptional and post-transcriptional modulation of IL-10 in CD8+ T lymphocytes and neutrophils.

KW - IL-10

KW - Immunomodulation

KW - IVIG

KW - SHLA-I

UR - http://www.scopus.com/inward/record.url?scp=77953293892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953293892&partnerID=8YFLogxK

U2 - 10.1007/s10875-009-9364-y

DO - 10.1007/s10875-009-9364-y

M3 - Article

C2 - 20127276

AN - SCOPUS:77953293892

VL - 30

SP - 384

EP - 392

JO - Journal of Clinical Immunology

JF - Journal of Clinical Immunology

SN - 0271-9142

IS - 3

ER -